Griseofulvin compound and pharmaceutical use thereof
US-11993593-B2 · May 28, 2024 · US
Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
US9108941B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9108941-B2 |
| Application number | US-200913141231-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 22, 2009 |
| Priority date | Dec 22, 2008 |
| Publication date | Aug 18, 2015 |
| Grant date | Aug 18, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention relates to compounds of the formula (I), where the symbols have the meaning given in the specification, for use in a method for treating cancer, to use of these compounds for the manufacture of a pharmaceutical composition for the treatment of cancer, and to methods of treatment for said diseases employing a compound of formula (I).
First claim
Opening claim text (preview).
The invention claimed is: 1. A compound of the formula (I) wherein the symbols in formula (I) have the following meanings: A is ═O, X is Cl, Y is —O—, Z is —(CH 2 ) n —, n is 0 or 1, R 2 is hydrogen or halogen, R 1 is, in case R 2 is hydrogen and n is other than 0: phenyl or pyridyl, wherein the phenyl, or…
Assignees
Inventors
Classifications
- C07D307/94Primary
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9108941B2 cover?
- The invention relates to compounds of the formula (I), where the symbols have the meaning given in the specification, for use in a method for treating cancer, to use of these compounds for the manufacture of a pharmaceutical composition for the treatment of cancer, and to methods of treatment for said diseases employing a compound of formula (I).
- Who is the assignee on this patent?
- Kraemer Alwin, Leber Blanka, Clausen Mads, and 4 more
- What technology area does this patent fall under?
- Primary CPC classification C07D307/94. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).